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Editorial on the Research Topic
Endocrine Diseases of Newborn: Epidemiology, Pathogenesis, Therapeutic Option
and Outcome
The aim of this collection is to provide information on recent advances and current thinking
in selected areas of Neonatal Endocrinology, as we believe that this area can be challenging in
presentation and management for both neonatologists and pediatric endocrinologists. To this end,
we invited several leaders in the field to contribute. In addition, we have included 3 manuscripts
submitted to Frontiers that fell within the remit of our topic.
The collection focuses on selected conditions presenting in the newborn consisting of a series of
10 mini-reviews, including some which may be considered the “go to” article for up-to-date science
and management of various conditions.
The neonatal period is complicated by unique physiology, because of the transition from
intrauterine life including the influence of maternal and placental hormones, and “normal” values
for hormone levels can be difficult to define, and many change with increasing postnatal age. The
measurement of hormone levels is further complicated by numerous additional circulating steroids
which may interfere with assays, and the challenges of small sample size. In the context of this
milieu the collection of articles ranges from common neonatal problems such as hypoglycemia
to rare disorders such as neonatal bone disease. The content of all the articles in the collection is
summarized below.
Bosch i Ara et al. provide an extensive review of congenital hypopituitarism, with a thorough
review of the science, including the known genetics, phenotype-genotype correlations, syndromic,
and non-syndromic hypopituitarism with helpful accompanying tables. They also provide a
comprehensive guide to the clinical presentation including red-flag symptoms and signs, diagnosis,
assessment and management of pituitary hormone deficiencies.
Di Dalmazi et al. present a study on the effect of maternal and neonatal factors on neonatal TSH
levels, using retrospective data from screening for congenital hypothyroidism in 62,132 infants in
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Abruzzo, Italy, a relatively iodine deficient area. As both sex and
postnatal age at collection affected the TSH level, they advocate
the use of locally derived TSH cut-offs for both and provide local
percentile charts for TSH based on their data. Effects of maternal
and neonatal factors were modest, but the study was limited by
data routinely collected in the screening programme and the
unknown contribution that iodine deficiency may have played in
this population.
Buonocore et al. describe causes of adrenal insufficiency,
with a focus on genetic conditions that present in the first few
months of life. This superb overview provides clear and concise
information on complex pathways and conditions, identifying
seminal features of presentation in a manner that is easy to read.
Testing for adrenal insufficiency was not in the remit of this
invited review, but assessment of the HPA axis can be found in
the review of congenital hypopituitarism by Bosch i Ara et al..
Balsamo et al. explore the breadth of conditions presenting
as congenital adrenal hyperplasia in the newborn period, and
provide insight into some of the rarer conditions. They describe
how clinical characteristics and diagnostic tests may be used to
distinguish between these, and how steroidogenic biochemistry is
evolving in this field. Therapeutic approaches are also included.
Li et al. from China present a systematic review and
meta-analysis of the screening results for congenital adrenal
hyperplasia involving 7.85 million newborns. The incidence of
1/23,024 was higher in males than females, possibly as a result
of the gender imbalance in China, the greater attention paid to
male infants resulting in a higher recall rate, or the diagnosis
of ambiguous genitalia before or after birth in females, making
screening unnecessary in girls.
With advancement in the genetic diagnosis of disorders of
sex development, Bertelloni et al. outline a different approach
to the investigation of 46XY DSD to the extensive, often
repeated and invasive laboratory testing, by using advanced
genetic technologies (next generation sequencing, whole exome
sequencing, targeted CGH array) as the first line test after
karyotyping and salt-loss exclusion which may result in a
molecular diagnosis and guide more targeted biochemical
investigations. A causative genetic diagnosis allows for accurate
prognosis and recurrence risk.
Lucaccioni et al. review the current understanding of
minipuberty and using this window as an opportunity for
the diagnosis, and potentially treatment, of babies with DSD
which could alter the natural history. They highlight the
hormonal changes that occur and how minipuberty modulates
neurobehavioral development.
Edwards and Harding review clinical aspects of transient
neonatal hypoglycemia. They discuss pathophysiology,
controversy over definitions of hypoglycemia, when and
how to make blood glucose measurements, and use of glucose gel
to prevent hypoglycemia. They highlight the need for evidence
as to whether transient asymptomatic hypoglycemia is associated
with brain injury, and if so, at what level or duration.
Chandran et al. report a family with a novel HNF4Amutation
presenting with differing phenotypic presentations of glucose
dysregulation. They describe an infant with diazoxide responsive
hyperinsulinaemic hypoglycemia, who shares a novel HNF4A
mutation with a sister who had transient neonatal hypoglycemia,
and his father who developed diabetes at the age of 15.
Implications of the genetic diagnosis on treatment and prognosis
are discussed.
Beardsall reviews hyperglycemia with a focus on the
preterm infant, and discusses pathogenesis, glucose insensitivity
and insulin resistance, relative insulin deficiency, the clinical
consequences of hyperglycemia, and its clinical management.
The review provides a wealth of information on underlying
mechanisms, whichmay be of particular value for neonatologists.
Beltrand et al. describe how the recent advances in neonatal
diabetes mellitus can guide management and how the known
genetic mutations define the pathophysiology by causing either
abnormal β-cell function or abnormal pancreatic morphology.
The authors provide a detailed clinical description of both
the permanent and transient forms. The challenge of insulin
therapy in maintaining normoglycaemia is discussed, as is the
management of those with mutations in the KATP channel with
suphonylureas to which the channel remain sensitive in 90% of
cases. A helpful appendix provides practical advice on switching
from insulin to glibenclamide, the oral suspension of which is
licensed for children in the European Union.
In the review of current insights into disorders of calcium
and phosphate in the newborn, Taylor-Miller and Allgrove
examine the current understanding of fetal-to-neonatal mineral
homeostasis mechanisms (calcium, phosphorus, magnesium)
as well as vitamin D. Recent genetic discoveries have shed
light on the pathophysiology of some causes of neonatal hypo
and hypercalcemia. The presentation and management of bone
fragility is discussed as well as the investigation and management
of disorders of calcium and phosphorus homeostasis.
Saraff et al. describe an approach to neonatal bone
disorders for clinicians, highlighting that early and accurate
diagnosis in these rare disorders can be important for
potentially life-saving treatment. The review includes
structural bone defects, and bone mineralization defects,
and an approach to diagnosis and management. This
practical approach could be extremely useful for
neonatal clinicians.
This series of articles was conceived with Dr. Paolo Ghirri,
Associate Professor of Pediatrics at the University of Pisa,
where he was the director of Neonatology at the Santa
Chiara. Following his sudden and untimely death during the
planning stage, we decided to dedicate the series to his life
and work and made our contributors aware of this at the time
of invitation.
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